Connection
Amy Franks to Clinical Trials as Topic
This is a "connection" page, showing publications Amy Franks has written about Clinical Trials as Topic.
|
|
Connection Strength |
|
|
|
|
|
0.241 |
|
|
|
-
Warmack TS, Estes MA, Heldenbrand S, Franks AM. Beta-adrenergic antagonists in hypertension: a review of the evidence. Ann Pharmacother. 2009 Dec; 43(12):2031-43.
Score: 0.072
-
Muldrew KM, Franks AM. Succinobucol: review of the metabolic, antiplatelet and cardiovascular effects. Expert Opin Investig Drugs. 2009 Apr; 18(4):531-9.
Score: 0.069
-
Franks AM, Gardner SF. AGI-1067: a novel vascular protectant for prevention of restenosis. Ann Pharmacother. 2006 Jan; 40(1):66-73.
Score: 0.055
-
Gardner SF, Franks AM. Olmesartan medoxomil: the seventh angiotensin receptor antagonist. Ann Pharmacother. 2003 Jan; 37(1):99-105.
Score: 0.045